Cantel Medical Corp/ US1380981084 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 3.4 bill.USD | 0.13% | 251.16 |
Assets
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 46.5000 | 52.7180 | 62.5410 | 74.6040 | 88.3380 | ||||||
| Intangible Assets | 75.9000 | 82.9520 | 85.8360 | 111.7190 | 124.5120 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | 372.2360 | 395.6700 | 471.7900 | 529.0020 | ||||||
| Inventories | 54.2000 | 59.7370 | 72.0780 | 91.4860 | 98.7240 | ||||||
| Accounts Receivable | 52.8000 | 62.2250 | 69.8050 | 93.3320 | 110.6560 | ||||||
| Cash and Cash Equivalents | 34.1000 | 31.7810 | 31.7200 | 28.3670 | 36.5840 | ||||||
| Current Assets | 150.7000 | 163.9090 | 188.3610 | 222.7420 | 257.3710 | ||||||
| Total Assets | 487.7000 | 536.1450 | 584.0310 | 694.5320 | 786.3730 | ||||||
Liabilities
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 13.3000 | 19.5290 | 16.1840 | 26.2630 | 27.4690 | ||||||
| Long-term debt | - | 80.5000 | 78.5000 | 116 | 126 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 21.2000 | 18.7000 | 26.2000 | 27.7000 | 27.9000 | ||||||
| Liabilities | 166.6000 | 170.8990 | 177.3980 | 240.1620 | 262.4410 | ||||||
| Share Capital | 4.5000 | 4.5640 | 4.5910 | 4.6080 | 4.6190 | ||||||
| Total Equity | 321.1000 | 365.2460 | 406.6330 | 454.3700 | 523.9320 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 487.7000 | 536.1450 | 584.0310 | 694.5320 | 786.3730 | ||||||
Income Statement
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 425 | 488.7490 | 565.0040 | 664.7550 | 770.1570 | ||||||
| Depreciation (total) | - | 18.8860 | 23.9570 | 25.0840 | 33.4520 | ||||||
| Operating Result | 63.2000 | 70.9280 | 80.7610 | 97.2510 | 110.4100 | ||||||
| Interest Income | -2.8400 | -2.3170 | -2.3640 | -3.3200 | -4.3030 | ||||||
| Income Before Taxes | 60.4000 | 68.6110 | 76.1910 | 93.9310 | 106.2330 | ||||||
| Income Taxes | 21.1000 | 25.3460 | 28.2380 | 33.9780 | 34.8550 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 39.2000 | 43.2650 | 47.9530 | 59.9530 | 71.3780 | ||||||
Per Share
Cash Flow
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 51.5000 | 64.2720 | 59.0700 | 80.2680 | 108.1930 | ||||||
| Cash Flow from Investing Activities | -52 | -47.4320 | -52.2940 | -112.9820 | -97.0620 | ||||||
| Cash Flow from Financing | 4.4000 | -18.9490 | -6.1050 | 29.9420 | -2.7510 | ||||||
| Decrease / Increase in Cash | 3.9000 | -2.2950 | -.0610 | -3.3530 | 8.2170 | ||||||
| Employees | 1,292 | 1,534 | 1,680 | 2,000 | 2,337 | ||||||
